Are Statins an Option in the Management of Abdominal Aortic Aneurysms?

被引:33
作者
Paraskevas, Kosmas I. [1 ,2 ]
Liapis, Christos D. [4 ]
Hamilton, George [2 ]
Mikhailidis, Dimitri P. [1 ,3 ]
机构
[1] Royal Free Hosp, Dept Clin Biochem, Vasc Dis Prevent Clin, London NW3 2QG, England
[2] Royal Free Hosp, Acad Dept Surg, London NW3 2QG, England
[3] Royal Free Univ Coll Med Sch, London WC1E 6BT, England
[4] Univ Athens, Dept Vasc Surg, Sch Med, Athens, Greece
关键词
statins; abdominal aortic aneurysms; perioperative mortality; AAA expansion rate;
D O I
10.1177/1538574407308205
中图分类号
R61 [外科手术学];
学科分类号
摘要
Medline was searched for studies investigating the perioperative and long-term results that derive from statin use in patients with abdominal aortic aneurysm and the clinical and experimental evidence dealing with aneurysm expansion. Data suggest that statins improve the perioperative and long-term outcomes of aneurysm operations and may also reduce expansion rates. International guidelines recommend the use of statins in these patients because abdominal aortic aneurysms are considered as a coronary heart disease equivalent. These guidelines do not appear to have been widely implemented. Preliminary results suggest that statins might play a role in the management of abdominal aortic aneurysms. Verification of these results in large-scale trials may hold implications for a more comprehensive approach of patients with abdominal aortic aneurysms as well as population-wide aneurysm screening programs. Irrespective of the role of statins on aneurysm expansion rates, it is important to ensure that all abdominal aortic aneurysm patients receive statin therapy to improve perioperative and long-term morbidity and mortality
引用
收藏
页码:128 / 134
页数:7
相关论文
共 68 条
[1]   The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial [J].
Ashton, HA ;
Buxton, MJ ;
Day, NE ;
Kim, LG ;
Marteau, TM ;
Scott, RAP ;
Thomspon, SG ;
Walker, NM .
LANCET, 2002, 360 (9345) :1531-1539
[2]   Clinical significance of pleiotropic effects of statins: Lipid reduction and beyond [J].
Auer, J ;
Berent, R ;
Weber, T ;
Eber, B .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (20) :1831-1850
[3]   Four-year follow up of patients with untreated abdominal aortic aneurysms [J].
Aziz, M ;
Hill, AA ;
Bourchier, R .
ANZ JOURNAL OF SURGERY, 2004, 74 (11) :935-940
[4]   Screening for abdominal aortic aneurysm [J].
Beard, JD .
BRITISH JOURNAL OF SURGERY, 2003, 90 (05) :515-516
[5]   Non-lipid-related effects of statins [J].
Bellosta, S ;
Ferri, N ;
Bernini, F ;
Paoletti, R ;
Corsini, A .
ANNALS OF MEDICINE, 2000, 32 (03) :164-176
[6]   HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J].
Bellosta, S ;
Via, D ;
Canavesi, M ;
Pfister, P ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1671-1678
[7]  
Bengtsson H, 1991, Eur J Vasc Surg, V5, P53
[8]   RUPTURED ABDOMINAL AORTIC-ANEURYSM - A POPULATION-BASED STUDY [J].
BENGTSSON, H ;
BERGQVIST, D .
JOURNAL OF VASCULAR SURGERY, 1993, 18 (01) :74-80
[9]  
Brady AR, 2002, NEW ENGL J MED, V346, P1445
[10]   The risk of rupture in untreated aneurysms: The impact of size, gender, and expansion rate [J].
Brown, PM ;
Zelt, DT ;
Sobolev, B .
JOURNAL OF VASCULAR SURGERY, 2003, 37 (02) :280-283